Skip Ribbon Commands
Skip to main content
Menu
Dr George Goh from SGH

Adj Asst Prof George Goh Boon Bee

​MBBS, MRCP (UK), M Med (Int Med), FAMS (Singapore)

Consultant

Specialty: Gastroenterology & Hepatology

Sub-specialties: Hepatology, Non-alcoholic Fatty Liver Disease, Viral Hepatitis, Cirrhosis, Liver Cancer, Liver Transplantation

Clinical Appointments

  • Consultant Gastroenterology & Hepatology Singapore General HospitalSingapore General Hospital

Profile

​Dr. George Goh is a Consultant Gastroenterologist and Hepatologist at the Singapore General Hospital. After Gastroenterology specialist training at Singapore General Hospital, he underwent further advanced subspecialty training in Hepatology at the Cleveland Clinic (USA), with a research focus on non-alcoholic fatty liver disease (NAFLD). He returned to establish a dedicated Metabolic Liver Clinic with multi-disciplinary involvement that helps to identify, prognosticate and manage patients with severe NAFLD. In addition, he remains actively involved in research and is the local Principal Investigator of several ongoing international NAFLD trials. He has published in the fields of NAFLD, liver cirrhosis, hepatocellular carcinoma and organ transplantation, and has been an invited faculty at both local and international conferences. He is an appointed Adjunct Assistant Professor at Duke-NUS Medical School and Clinical Lecturer at Yong Loo Lin School of Medicine, National University of Singapore. He is the current Chairman of the National Foundation of Digestive Disease (NFDD), which aims to increase awareness of such diseases among the general public.

Education

  • ​MBBS
  • MRCP (UK)
  • M Med (Int Med)
  • FAMS (Singapore)

Professional Appointments and Committee Memberships

  • Adjunct Assistant Professor, Duke-NUS Medical School
  • Clinical Lecturer, NUS Yong Loo Lin School of Medicine
  • Fellow of Academy of Medicine, Singapore (FAMS)
  • Member, American Association for the Study of Liver Disease (AASLD)
  • Chairperson, Executive committee, National Foundation of Digestive Diseases, Singapore 

Awards

  • ​Gold Award Singapore Health Quality Service Awards 2017
  • SingHealth Publish awards 2016
  • AASLD 2016 Poster of distinction
  • Service with a Heart award November 2015
  • SingHealth Publish awards (Outstanding) 2015
  • Human Manpower Development Plan (HMDP) Fellowship Award 2013: Cleveland Clinic
  • Singapore Health Quality Service Award 2011- 2012: Gold
  • Service with a Heart award March 2012
  • SingHealth 2012 Best registrar award
  • SingHealth 2011 Best registrar award
  • AASLD 2010 Poster of distinction
  • APDW 2009 Travel award

Research Interests

Publications and Research Trials

​PE Chang, BBG Goh, V Ekstrom, ML Ong, CK Tan. Low serum albumin predicts early mortality in patients with severe hypoxic hepatitis. World Journal of Hepatology 2017;9(22):959-966.

JW Li, GBB Goh, PE Chang, CK Tan. BCLC Outperforms HKLC Staging of Hepatocellular Carcinoma in Multiethnic Asians – Real-World Perspective. World Journal Gastroenterology 2017;23(22): 4054-63

BBG Goh, JW Li, PE Chang, CY Lin, KY Chow, CK Tan. Deciphering the epidemiology of hepatocellular carcinoma through the passage of time; a study of 1401 patients across three decades. Hepatology Communications 2017;1 (6): 564-71.

MC Cheah, AJ McCullough, GBB Goh. Current modalities of fibrosis assessment in Non-Alcoholic Fatty Liver Disease. Journal of Clinical and Translational Hepatology 2017; 5(3):1-11.

T Singh, G Kochhar, GBB Goh, P Schauer, S Brethauer, M Kroh, A Aminian, R Lopez, S Dasarathy, A McCullough.Safety and Efficacy of Bariatric Surgery in Patients with Advanced Fibrosis. International Journal of Obesity 2017 Mar; 41(3):443-449.

GBB Goh, P An, WC Chow, JM Yuan, WP Koh. Association between diabetes mellitus and cirrhosis mortality: The Singapore Chinese Health Study. Liv Int 2017 Feb;37(2):251-258

Salazar E, Tan CK, Goh BB. “Broken Heart” in Acute on Chronic Liver Failure: Case report. Proceedings of Singapore Healthcare 2016;1-2 (DOI: 10.1177/2010105816667366)

JH Ngu, GBB Goh, ZX Poh, R Soetikno. Managing Non Alcoholic Fatty Liver Disease. SMJ 2016 57(7):1-4.

J Chang, Goh BB, Tan CK. Low serum albumin and advanced age predict early mortality in Asian patients with extreme elevations of serum aminotransferases. J Dig Dis 2016 17(3): 193-201.

GBB Goh, AJ McCullough. The Natural History of NAFLD. Dig Dis Sci 2016 61(5): 1226-33.

Z Poh, L Shen, HI Yang, W Seto, VW Wong, CY Lin, BBG Goh, PE Chang, H Chan, Man-FY, CJ Chen, CK Tan. Real World Risk Score for Hepatocellular Carcinoma (RWS-HCC): a clinically practical risk predictor for HCC in chronic hepatitis B. Gut 2016 65(5): 887-8.

R Kumar & GBB Goh. Chronic hepatitis B and Fatty liver-issues in clinical management. Clinics and Research in Hepatology & Gastroenterology 2016 2016 Dec;40(6):755-759

GBB Goh, D Issa, Pagadala MR, Dasarathy J, Unalp-Arida A, Sargent R, Hawkins C, Sourianarayanane A, Khiyami A, Yerian L, Pai R, Dasarathy S., Naim Alkhouri, McCullough AJ. The Development of a Non-invasive Model to Predict the Presence of Nonalcoholic Steatohepatitis. Jou Gastro Hep 2016 31(5): 995-1000.

WP Koh, YY Dan, GBB Goh, A Jin, R Wang, JM Yuan. Dietary fatty acids and risk of hepatocellular carcinoma in the Singapore Chinese Health Study. Liver Int 2016 36 (6):893-901.

PE CHANG, GBB GOH, JH NGU, HK TAN, CK TAN. Clinical applications, limitations and future role of transient elastography in the management of liver disease. World J Gastrointest Pharmacol Ther. 2016 Feb 6;7(1):91-106

GBB GOH, PE CHANG, CK TAN. Changing epidemiology of hepatocellular carcinoma in Asia. Best Pract Res Clin Gastroenterol. 2015 Dec; 29(6):919-28.

GBB Goh, C Kwan, SY Lim, NKK Venkatanarasimha, R Abu Bakar, TL Krishnamoorthy, HH Shim, KH Tay, WC Chow. Perceptions of Non Alcoholic Fatty Liver Disease – An Asian Community Based Study. Gastroenterology Reports 2016 4(2): 131-5.

Poh ZX, Goh GB, Chang PJ, Tan CK. Rates of cirrhosis and hepatocellular carcinoma in chronic hepatitis B and the role of surveillance in a 10 year follow-up of 673 patients. Eur Jou Gastro Hep. 2015 Jun;27(6):638-43

GBB Goh, Pagadala MR, Dasarathy J, Unalp-Arida A, Sargent R, Hawkins C, Sourianarayanane A, Khiyami A, Yerian L, Pai R, Dasarathy S.,McCullough AJ. Age impacts ability of aspartate-alanine aminotransferase ratio to predict advanced fibrosis in non-alcoholic fatty liver disease. Dig Dis Sci. 2015 Jun;60(6):1825-31

GBB Goh, Pagadala MR, Dasarathy J, Unalp-Arida A, Sargent R, Hawkins C, Sourianarayanane A, Khiyami A, Yerian L, Pai R, Dasarathy S.,McCullough AJ. Clinical spectrum of Non-Alcoholic Fatty Liver Disease in diabetic and non-diabetic patients. Biochimica et Biophysica Acta (BBA) Clinical 2015;3:141-145
 
Hawkins C, Sourianarayanane A, Khiyami A, Yerian L, Pai R, McCullough AJ, Dasarathy S. Renin-angiotensin system and fibrosis in non-alcoholic fatty liver disease.  Liver Int. 2015;35(3):979-85.

GBB Goh, WC Chow, RW Wang, JM Yuan, WP Koh. Coffee, Alcohol, and Other Beverages in Relation to Cirrhosis Mortality: The Singapore Chinese Health Study. Hepatology 2014; 60(2):661-669.

GBB Goh , ZW Mok, ZR Mok, JP Chang, CK Tan. Organ donation: what else can be done besides legislature? Clin Transplant.2013 Nov-Dec; 27(6):E659-64. doi: 10.1111/ctr.12244.

BBG Goh, DMY Tan, KL Ling. Knowledge and Attitudes of Junior Medical Doctors towards Gastric Cancer. Proceedings of Singapore Healthcare 2012; 21(3)2: 161-166.

Research Trials